Completed PHASE4 INTERVENTIONAL 1-arm NCT01295606

Cefazolin Pharmacokinetics: Elimination Clearance in Neonates

Sponsor: Universitaire Ziekenhuizen KU Leuven

Interventions Cefazolin

Updated 6 times since 2017 Last updated: Dec 12, 2011 Started: Feb 28, 2011 Primary completion: Dec 31, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01295606, this PHASE4 trial focuses on Prophylaxis and remains completed. Sponsored by Universitaire Ziekenhuizen KU Leuven, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Nov 2022 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Nov 2022 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universitaire Ziekenhuizen KU Leuven

Data source: Universitaire Ziekenhuizen KU Leuven

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.